188 related articles for article (PubMed ID: 23645041)
1. Influence of survivin (BIRC5) and caspase-9 (CASP9) functional polymorphisms in renal cell carcinoma development: a study in a southern European population.
Marques I; Teixeira AL; Ferreira M; Assis J; Lobo F; Maurício J; Medeiros R
Mol Biol Rep; 2013 Aug; 40(8):4819-26. PubMed ID: 23645041
[TBL] [Abstract][Full Text] [Related]
2. Functional promoter -31G>C variant in survivin gene is associated with risk and progression of renal cell cancer in a Chinese population.
Qin C; Cao Q; Li P; Ju X; Wang M; Chen J; Wu Y; Meng X; Zhu J; Zhang Z; Lu Q; Yin C
PLoS One; 2012; 7(1):e28829. PubMed ID: 22295057
[TBL] [Abstract][Full Text] [Related]
3. Correlation between survivin genetic polymorphisms and lung cancer susceptibility.
Guo G; Zhang Q; Yu Z; Li J; Ding Z; Li J; Tan W
Int J Clin Exp Pathol; 2015; 8(6):7426-30. PubMed ID: 26261647
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms of caspase 8 and caspase 9 gene and colorectal cancer susceptibility and prognosis.
Theodoropoulos GE; Gazouli M; Vaiopoulou A; Leandrou M; Nikouli S; Vassou E; Kouraklis G; Nikiteas N
Int J Colorectal Dis; 2011 Sep; 26(9):1113-8. PubMed ID: 21538054
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia and renal cell carcinoma: The influence of HIF1A+1772C/T functional genetic polymorphism on prognosis.
Ferreira M; Teixeira A; Maurício J; Lobo F; Morais A; Medeiros R
Urol Oncol; 2017 Aug; 35(8):532.e25-532.e30. PubMed ID: 28476527
[TBL] [Abstract][Full Text] [Related]
6. BIRC5 promoter SNPs do not affect nuclear survivin expression and survival of malignant pleural mesothelioma patients.
Hmeljak J; Erčulj N; Dolžan V; Kern I; Cör A
J Cancer Res Clin Oncol; 2011 Nov; 137(11):1641-51. PubMed ID: 21861135
[TBL] [Abstract][Full Text] [Related]
7. The association between the survivin -31G/C promoter polymorphism and hepatocellular carcinoma risk in a Turkish population.
Bayram S; Akkız H; Bekar A; Akgöllü E
Cancer Epidemiol; 2011 Dec; 35(6):555-9. PubMed ID: 21296634
[TBL] [Abstract][Full Text] [Related]
8. Functional polymorphism -31C/G in the promoter of BIRC5 gene and risk of nasopharyngeal carcinoma among chinese.
Ma F; Zhang H; Zhai Y; Huang W; Zhao C; Ou S; Zhou H; Yuan W; Wang Z; Wang H; Yue W; Yu L; Li P; Xia X; Cai M; Zhang Y; Cui Y; He F; Ma Y; Zhou G
PLoS One; 2011 Feb; 6(2):e16748. PubMed ID: 21304814
[TBL] [Abstract][Full Text] [Related]
9. [A study on the expression of CASP9 gene and its polymorphism distribution in non-small cell lung cancer].
Lou Y; Fang CQ; Li JH
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Feb; 24(1):59-62. PubMed ID: 17285546
[TBL] [Abstract][Full Text] [Related]
10. Role of survivin re-expression in the development and progression of non-small cell lung cancer.
Javid J; Mir R; Julka PK; Ray PC; Saxena A
Tumour Biol; 2015 Jul; 36(7):5543-50. PubMed ID: 25677909
[TBL] [Abstract][Full Text] [Related]
11. Analysis of polymorphism in the survivin gene promoter as a potential risk factor for head and neck cancers development.
Kostić M; Nikolić N; Ilić B; Carkić J; Milenković S; Vukadinović M
Srp Arh Celok Lek; 2013; 141(5-6):304-7. PubMed ID: 23858797
[TBL] [Abstract][Full Text] [Related]
12. Survivin -31G/C promoter polymorphism and sporadic colorectal cancer.
Gazouli M; Tzanakis N; Rallis G; Theodoropoulos G; Papaconstantinou I; Kostakis A; Anagnou NP; Nikiteas N
Int J Colorectal Dis; 2009 Feb; 24(2):145-50. PubMed ID: 18946675
[TBL] [Abstract][Full Text] [Related]
13. Effects of Caspase 9 Gene Polymorphism in Patients with Prostate Cancer.
Yilmaz SG; Yencilek F; Yildirim A; Yencilek E; Isbir T
In Vivo; 2017; 31(2):205-208. PubMed ID: 28358701
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms of survivin and its protein expression are associated with colorectal cancer susceptibility in Chinese population.
Li XB; Li SN; Yang ZH; Cao L; Duan FL; Sun XW
DNA Cell Biol; 2013 May; 32(5):236-42. PubMed ID: 23581553
[TBL] [Abstract][Full Text] [Related]
15. Association between survivin gene polymorphisms and the susceptibility to colon cancer development in the Turkish population.
Yamak N; Yaykasli KO; Yilmaz U; Eroz R; Uzunlar AK; Ankarali H; Sahiner C; Baltaci D
Asian Pac J Cancer Prev; 2014; 15(20):8963-7. PubMed ID: 25374237
[TBL] [Abstract][Full Text] [Related]
16. Association of vascular endothelial growth factor polymorphisms with clinical outcome of renal cell carcinoma patients.
Zhong W; Wang X; Pan B; Su Z
Tumour Biol; 2014 Oct; 35(10):9839-45. PubMed ID: 24989926
[TBL] [Abstract][Full Text] [Related]
17. The effect of polymorphisms in the promoter of the BIRC5 gene on the risk of oesophageal squamous cell carcinoma and patient's outcomes.
Wang N; Li Y; Zhou RM; Cui SJ; Cao SR; Huang X; Huo XR; Shan BE
Mutagenesis; 2019 Dec; 34(4):307-313. PubMed ID: 31165868
[TBL] [Abstract][Full Text] [Related]
18. Caspase 8 and caspase 9 gene polymorphisms and susceptibility to gastric cancer.
Liamarkopoulos E; Gazouli M; Aravantinos G; Tzanakis N; Theodoropoulos G; Rizos S; Nikiteas N
Gastric Cancer; 2011 Oct; 14(4):317-21. PubMed ID: 21461653
[TBL] [Abstract][Full Text] [Related]
19. The CASP8 -652 6N insertion/deletion promoter polymorphism is associated with renal cell carcinoma risk and metastasis.
de Martino M; Haitel A; Schatzl G; Klingler HC; Klatte T
J Urol; 2013 Aug; 190(2):717-22. PubMed ID: 23313206
[TBL] [Abstract][Full Text] [Related]
20. GNAS1 (Gαs) gene T393C polymorphism and renal cell carcinoma risk in a North Indian population: a case-control study.
Arjumand W; Ahmad ST; Nafees S; Ali N; Rashid S; Seth A; Sultana S
Genet Test Mol Biomarkers; 2012 Sep; 16(9):1062-6. PubMed ID: 22931242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
